SS Innovations International (SSII) Total Current Liabilities (2016 - 2026)
SS Innovations International's (SSII) quarterly Total Current Liabilities came in at $26.0 million in Q1 2026, up 73.67% year-on-year from $15.0 million in Q1 2025, and down 0.75% quarter-over-quarter from $26.2 million in Q4 2025.
SS Innovations International (SSII) Total Current Liabilities (2016 - 2026) Analysis & Trends
SS Innovations International has disclosed Total Current Liabilities across 11 years of filings, most recently posting $26.0 million for Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $26.0 million, up 73.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $26.0 million (up 73.67% YoY), and the FY2025 annual result was $26.2 million, up 23.03% from the prior year.
- Total Current Liabilities came in at $26.0 million for Q1 2026 at SS Innovations International, down from $26.2 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $26.2 million in Q4 2025 to a low of $221585.0 in Q2 2022.
- The 5-year median for Total Current Liabilities is $13.0 million (2024), against an average of $12.7 million.
- Across the five-year window, Total Current Liabilities tumbled 82.93% in 2022 and surged 3525.46% in 2023, its largest moves.
- SS Innovations International's Total Current Liabilities stood at $7.8 million in 2022, then rose by 9.11% to $8.5 million in 2023, then jumped by 151.72% to $21.3 million in 2024, then climbed by 23.03% to $26.2 million in 2025, then slipped by 0.75% to $26.0 million in 2026.
- The last three Total Current Liabilities figures came in at $26.0 million (Q1 2026), $26.2 million (Q4 2025), and $21.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 9.50 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.22 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.15 Bn |
| 10 | SS Innovations International | 689.95 Mn | 666.34 Mn | 5.33 Mn | 26.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.05 Mn |
| Dec 31, 2025 | 26.24 Mn |
| Sep 30, 2025 | 21.19 Mn |
| Jun 30, 2025 | 19.61 Mn |
| Mar 31, 2025 | 15.00 Mn |
| Dec 31, 2024 | 21.33 Mn |
| Sep 30, 2024 | 18.50 Mn |
| Jun 30, 2024 | 14.98 Mn |
| Mar 31, 2024 | 13.03 Mn |
| Dec 31, 2023 | 8.47 Mn |
| Sep 30, 2023 | 8.50 Mn |
| Jun 30, 2023 | 8.03 Mn |
| Mar 31, 2023 | 5.12 Mn |
| Dec 31, 2022 | 7.77 Mn |
| Sep 30, 2022 | 1.32 Mn |
| Jun 30, 2022 | 221,585.00 |
| Mar 31, 2022 | 278,250.00 |
| Dec 31, 2021 | 287,281.00 |
| Sep 30, 2021 | 1.28 Mn |
| Jun 30, 2021 | 1.30 Mn |